Is Chicory Root Fiber Satiety Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Chicory Root Fiber Satiety Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Background Gastrointestinal (GI) disorders associated with increased gastric acid secretion, such as gastroesophageal reflux, dyspepsia, bloating, and abdominal pain, significantly impair quality of life and present a substantial healthcare burden. [Teterovska R (2025); evidence level 4] - Discrepancies between product information and available scientific evidence highlight regulatory and consumer protection challenges. [Teterovska R (2025); evidence level 4] - Conventional therapies may have limited efficacy or undesirable side effects, underscoring the need for safe complementary approaches. [Teterovska R (2025); evidence level 4] - Interestingly, we previously found that short-term (3 weeks), daily intake of 30 g/day of dried chicory root fibers in individuals at risk of T2D rapidly modulated the gut microbiota by increasing relative levels ofspp. [Omary Lina (2025); evidence level 4] - Interestingly, we show a pivotal role of the intrinsic chicory root fibers in modulating microbial butyrate production pathways and fecal SCFA concentrations, as well as whole-body insulin sensitivity, insulin-mediated non-oxidative glucose disposal, fasting circulating glucose, and triglyceride (TG) concentrations with trends toward an increased peripheral insulin sensitivity and reduced liver fat accumulation. [Omary Lina (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.